Just posted on Facebook by one of the posters. SIO To

New Post Public Reply Private Reply Replies (3) Message Board
SIObserver
Just posted on Facebook by one of the posters.

SIO

To understand the current issue in Lakeshore with CEN Biotech, it is important first to understand some basic terminology in land use planning: primarily “permitted use” and “legal non-conforming use”. It is the second term which I would like to focus on. This statutory protection within Ontario, and in the Supreme Court, is also describes it as, “the doctrine of acquired rights”.
“Zoning” is the process which creates areas where land can only be used in certain ways based on the zoning classification. Each zone has a list of uses that are permitted and any uses outside of that are presumptively not permitted.
The courts have determined that zoning changes cannot end a use that was already legal before the change in the zoning took place. And so the doctrine of legal non-conforming use was established. As long as the use of the land does not change, then the use can continue.
This law is built to protect land and business owners from unfair changes or additional bylaw creation that might otherwise place restrictions on the use of the existing property.
In Ontario, the doctrine of legal non-conforming use can be found in Section 34(9) of the Planning Act.
PART V, LAND USE CONTROLS AND RELATED ADMINISTRATION
Excepted lands and buildings
(9) No by-law passed under this section applies,
(a) to prevent the use of any land, building or structure for any purpose prohibited by the by-law if such land, building or structure was lawfully used for such purpose on the day of the passing of the by-law, so long as it continues to be used for that purpose; or
(b) to prevent the erection or use for a purpose prohibited by the by-law of any building or structure for which a permit has been issued under subsection 8 (1) of the Building Code Act, 1992, prior to the day of the passing of the by-law, so long as the building or structure when erected is used and continues to be used for the purpose for which it was erected and provided the permit has not been revoked under subsection 8 (10) of that Act. R.S.O. 1990, c. P.13, s. 34 (9); 2009, c. 33, Sched. 21, s. 10 (1).
The Supreme Court of Canada also made it clear in Saint-Romuald (City) v. Olivier that the use can be intensified, so long as it does not change in “kind”.
But let’s first examine what the law says, and then we will go through some point of facts regarding the situation surrounding CEN Biotech and the town.
Simply put, this Ontario Planning Act, RSO 1990 law makes it crystal clear that CEN Biotech is protected from any by-law creation that would prohibit the use of its land or buildings from operating under its intended use as long as the use of the property does not change after a new bylaw is created that would restrict its use.
While many are concerned, the idea that Lakeshore possesses a legitimate ability or concerning intent to create a by-law that would either restrict CEN Biotech from operating, or would require them to re zone or reapply for new permits under this new by-law is quite simply ridiculous, as this law was specifically created to protect land and building owners for this exact situation.
In order for the town of Lakeshore to have any leg to stand on in regards to interfering with the use of the property, several factors would need to be in play at the same time:
1) CEN Biotech would need to be attempting to change the use of the property to another use entirely. Such as changing from an impound lot to a cabbage patch.
2) CEN Biotech would have to be attempting to change the use of the property after a by-law was created that would restrict the use of the land for the new purpose.
3) CEN Biotech would need to be pre-permit stage. They would need to be still seeking a permit for the buildings structures at the time the new bylaw was passed.
Obviously, CEN Biotech has not found itself under any one of those 3 conditions, let alone even 1. Thus the issue remains plain as day that CEN Biotech has complete rights in continuing to acquire its MMPR license from Health Canada, and to proceeding with operations under such MMPR in its current agricultural conforming condition, and further more; “No by-law passed under this section applies to prevent the use of…” because CEN Biotech has not changed the use of its property and no such by-law has existed.
In fact, until any proposed by-laws are passed and enacted, CEN Biotech even has full legal rights to purchase and develop additional agricultural property for its medical marijuana operations as long as the building permits are acquired and use of the property is determined prior to the passing of the new restrictive by-law.
I’m now also going to give you some excerpts from the Canadian justice review board archive entitled:
“The Planning Act: What’s New, What Remains, What You Should Know”
“The purpose of this paper is to provide an overview, with examples where helpful, of
how the Ontario Municipal Board (the “Board”) and the Courts have interpreted and
applied the wording of subsection 34(9).”

I have given an excerpt to show the intent of the paper and I will now give some examples of existing uses when by-laws are passed:

(ii) Use of Buildings or Structures on the Day the By-law was Passed
A use will not lose its non-conforming character by virtue of expanding the use to the
entire building or structure, as long as the owner maintains an intention to make such use
of the building or structure. For example, in Re Hartley and City of Toronto,13 an
association purchased a duplex residential building as a home for juvenile girls two days
before a by-law was passed to prohibit such a use. The Association occupied the upper
dwelling unit, while the lower dwelling unit was continued to be occupied by the
previous owners. The question before the Court was whether the use of only part of the
premises constituted “using for purposes prohibited by the by-law”. The Court found that
where possession has been taken so far as it can be and in good faith for the purpose for
which the building was acquired, the ingredients for protection are met:
“The test of the bona fides of the user must be whether the acts done disclose a
real intention to use the building for its intended purposes and an actual user so
far as that purpose could be carried out at the time.”14

The Supreme Court had the opportunity to consider almost the identical facts in a case
called Central Jewish Institute v. Toronto.
15 In that case, a private school purchased
property with the intention to conduct schooling services on the premises. At the time
that the land was purchased, schooling was permitted under the by-law. When it became
clear that the by-law was about to be amended to prohibit its proposed activities, the
school arranged for a number of teachers and students to be present on the premises prior
to the passing of the by-law. The Supreme Court found that it was not necessary that the
entire premises be used as a school at the time the by-law was passed to be afforded
protection for the entire building. The Supreme Court also confirmed that, while an
intention to use the building is not sufficient in and of itself to determine whether
protection should be afforded to the owners, it is “an important element in considering
evidence as to actual user.”16

OK. So clearly CEN Biotech has a bona fide intent to operate a large scale medical marijuana grow operation. That could not be clearer. However, what about in if CEN Biotech wishes to expend the buildings purpose or significantly increase capacity through expansion?

As was noted in Re Hartley and Central Jewish Institute above, the Courts have found
that the entire building or structure for which a legal non-conforming use is being made
enjoys the exemption from the zoning by-law, as long as the intention of the owner to use
the building or structure for that purpose was bona fide. However, the analysis is not so
clear when the building or structure has been reconfigured to allow additional density of
use. It may be that this increased density will disentitle the owner from relying on the
protection of subsection 34(9). For example, in R. v. Grant17 the Ontario Court of Appeal
found that a legal non-conforming two-unit apartment building could not be extended
into a four-unit apartment dwelling, and similarly in Weisburg v. Kingston (City),18 the
Court refused to permit the extension of a legal non-conforming four unit dwelling to a
five unit dwelling. Instructive for this issue may be the impact of intensification, as
discussed in Saint-Romuald v. Olivier, which case is discussed below.

So it appears that the only real danger to CEN Biotech could perhaps be that they may experience some difficulty in expanding the build out of the facility to the entire 10.3 acres. However, this is not a cut and dry matter as we see in certain methods of evaluation in preexisting use was demonstrated by a test in determining expansion criteria under the scope of previous by-laws.

4. To the extent activities are added, altered or modified within the scope of the
original purpose (i.e., activities that are ancillary to, or [page921] closely related to, the
pre-existing activities), the Court has to balance the landowner's interest against the
community interest, taking into account the nature of the pre-existing use (e.g., the
degree to which it clashes with surrounding land uses), the degree of remoteness (the
closer to the original activity, the more unassailable the acquired right) and the new or
aggravated neighbourhood effects (e.g., the addition of a rock crusher in a residential
neighbourhood is likely to be more disruptive than the addition of a fax machine). The
greater the disruption, the more tightly drawn will be the definition of the pre-existing
use or acquired right. This approach does not rob the landowner of an entitlement. By
definition, the limitation applies only to added, altered or modified activities.

So here we see demonstrated that it is the Court’s stance that it must balance the landowner's interest against the community interest, taking into account the nature of the pre-existing use. However, although the narrower pre-existing condition may be held to more tightly after a restrictive by-law is passed, the situation surrounding CEN Biotech is a little unusual in that a formal plan and intent has been supplied to and approved by the Canadian government for a full 1.3 million lb capacity which seems to have addressed the concern of density of use prior to this situation arising.
Therefore it is my belief that CEN Biotech will maintain legal grounding under the protection of the doctrine of acquired rights in their expansion and build out of the entire property even if is if Lakeshore passes supplementary restrictive by-laws. Of course Lakeshore also has the right to amend their added by-laws to make it an easier process for CEN Bio expansion later down the road, through once a government facility is classified and operational under health Canada’s jurisdiction, I believe this will be who holds the cards.

I hope this helps you to form an opinion about the current state of your investment in FITX, and to highlight what may be the real questions in this situation, and what may be baseless fear. I believe we as investors can rest easy on the matter of both zoning for current build outs and licensing from health Canada.

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 198

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 254

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 295

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 178

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 149

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 259

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 259

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 220

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 239

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading
Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 210

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Offering: Capital Southwest's $350 Million Bond Deal

Updated Category News Views 209

Capital Southwest Corporation's Noteworthy Bond Offering Capital Southwest Corporation (NASDAQ: CSWC) has made headlines with its recent pricing of a public offering, amounting to a significant $350 million in 5.950% notes due in 2030. This strategic financial move showcases the Company’s commitment to expanding its investment capabilities while ensuring a stable...

Continue Reading
Nektar Therapeutics Enhances CAR-T Efficacy with NKTR-255

Updated Category News Views 392

Nektar Therapeutics Elevates CAR-T Therapy with NKTR-255 Nektar Therapeutics (Nasdaq: NKTR) has recently showcased remarkable findings from its Phase 2 clinical trial, emphasizing the efficacy of its investigational treatment NKTR-255. This new therapy aims to enhance the effectiveness of CD19-directed CAR-T cell therapy in patients suffering from relapsed or refractory...

Continue Reading
Motorcycle Accessories Market Expected to Hit $33.85 Billion

Updated Category News Views 132

Growth Potential in the Motorcycle Accessories Market The motorcycle accessories market is set for substantial growth, showing a remarkable increase from USD 21.18 billion in 2025 to an estimated USD 33.85 billion by 2034. This surge indicates a Compound Annual Growth Rate (CAGR) of 5.35%. Such an escalation in market size reflects broader trends in consumer behavior and...

Continue Reading
Dealerlogix Joins GM's 3Synergy Program to Enhance Services

Updated Category News Views 584

Dealerlogix Enters GM’s 3Synergy Program Dealerlogix, powered by Vehlo, has successfully joined General Motors' 3Synergy service lane tool program. This innovative fixed operations platform offers GM dealers a robust, all-in-one solution designed to enhance service department efficiency. With a range of customizable features, Dealerlogix aims to automate vital...

Continue Reading
Growth of PD-(L)1 Inhibitors in Oncology Highlighted by Trends

Updated Category News Views 140

Emerging Trends in the PD-(L)1 Inhibitors Market As innovations in immunotherapy continue to shape cancer treatment, the PD-(L)1 inhibitors market is witnessing significant growth. These therapies are redefining patient outcomes across various cancers, prompting both researchers and pharmaceutical companies to invest heavily in this evolving space. Understanding PD-(L)1...

Continue Reading